미 연방거래위원회, FTC, States Ask Federal

미 연방거래위원회가(Federal Trade Commission) 2026-10-13 공개한 'FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry' 발표를 바탕으로, 확인 가능한 사실을 중심으로 정리했습니다.

핵심 내용과 국내 파급력

The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry. 우주·과학 분야 발표는 국내 연구기관, 대학, 항공우주 산업 종사자가 기술 협력 흐름을 살필 때 참고할 만합니다. 임무 일정, 관측 장비, 연구 목표처럼 원문에 적힌 고유 정보를 중심으로 보는 것이 좋습니다.

어떤 발표인가

• In a motion and brief filed today, the FTC and its state co-plaintiffs allege that Shkreli, since his release from prison in May 2022, has been violating the court order by publicly trading in pharmaceutical industry stocks and broadcasting his opinions about the business and management of many pharmaceutical industry companies.
• “After a full trial, the court found that Martin Shkreli’s conduct drove up prescription drug costs for American patients and blocked the entry of lower-cost generics,” said Daniel Guarnera, Director of the FTC’s Bureau of Competition.
• “When judgment is entered by a court, whether it’s a settlement or an order following a trial, defendants must fulfill their obligations.
• Today’s action should serve as notice that the FTC will not hesitate to enforce violations of court orders." The FTC voted unanimously in January 2020 to initiate the case against Shkreli, another individual executive and the companies they founded, Vyera Pharmaceuticals LLC and Phoenixus AG.
• District Court for the Southern District of New York ruled that Shkreli organized an illegal anticompetitive scheme to perpetuate a monopoly for the life-saving drug Daraprim, a treatment for a rare, potentially fatal parasitic infection known as toxoplasmosis.

발표에서 확인되는 내용

• The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry
• In a motion and brief filed today, the FTC and its state co-plaintiffs allege that Shkreli, since his release from prison in May 2022, has been violating the court order by publicly trading in pharmaceutical industry stocks and broadcasting his opinions about
• “After a full trial, the court found that Martin Shkreli’s conduct drove up prescription drug costs for American patients and blocked the entry of lower-cost generics,” said Daniel Guarnera, Director of the FTC’s Bureau of Competition
• “When judgment is entered by a court, whether it’s a settlement or an order following a trial, defendants must fulfill their obligations
• Today’s action should serve as notice that the FTC will not hesitate to enforce violations of court orders."

숫자와 고유명사

• The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry
• In a motion and brief filed today, the FTC and its state co-plaintiffs allege that Shkreli, since his release from prison in May 2022, has been violating the court order by publicly trading in pharmaceutical industry stocks and broadcasting his opinions about
• “After a full trial, the court found that Martin Shkreli’s conduct drove up prescription drug costs for American patients and blocked the entry of lower-cost generics,” said Daniel Guarnera, Director of the FTC’s Bureau of Competition
• “When judgment is entered by a court, whether it’s a settlement or an order following a trial, defendants must fulfill their obligations
• Today’s action should serve as notice that the FTC will not hesitate to enforce violations of court orders."

한눈에 보는 원문 기준

원문 확인

• Federal Trade Commission 공식 자료

에디터의 시사점 (Key Takeaways)

• 미 연방거래위원회 발표의 적용 대상과 조치 범위를 원문에서 구분합니다.
• 한국 기업·소비자는 'FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry'과 직접 연결되는 거래나 서비스가 있는지 점검합니다.
• Federal Trade Commission의 시행일과 후속 문서가 공개되는지 확인합니다.